Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Johnson & Johnson : J&J in $4 Billion Settlement Talks

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/12/2013 | 11:16pm CEST

Johnson & Johnson (JNJ) has agreed to pay $4 billion to settle more than 7,500 lawsuits over the company's recalled hip-implant products, Bloomberg News reported Tuesday, citing three people familiar with the agreement.

The settlement will be announced next week, Bloomberg reported.

Full story at: www.bloomberg.com/news/2013-11-12/j-j-said-to-reach-4-billion-deal-to-settle-hip- awsuits.html

Write to nymonitoring@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on JOHNSON & JOHNSON
09:26p JOHNSON & JOHNSON : To Pay $417m To Ovarian Cancer Victim
07:04p JOHNSON & JOHNSON : $417M verdict against Johnson's baby powder gives hope to Je..
04:31p JOHNSON & JOHNSON : Bavarian Nordic A S Announces Major Shareholder Notification..
01:54p BAVARIAN NORDIC A/S : Announces Major Shareholder Notification from Johnson & Jo..
01:10p JOHNSON & JOHNSON : Massive California verdict expands J&J's talc battlefield
01:10p JOHNSON & JOHNSON : Massive California verdict expands J&J's talc battlefield
10:15a JOHNSON & JOHNSON : ordered to pay $417M to cancer patient Eva Echevarria
08/22 JOHNSON & JOHNSON : $$417 million in damages awarded in baby powder lawsuit
08/22 JOHNSON & JOHNSON : In brief
08/22DJJOHNSON & JOHNSON : J&J Wades Into Death Penalty Debate for the First Time -- Up..
More news
News from SeekingAlpha
11:53a The Top 5 Healthcare Dividend Stocks Today
10:36a $417M California verdict in J&J baby powder case suggests forum-shopping - le..
10:00a MEDTRONIC : You Have To Look At It The Right Way
09:00a RETIREMENT STRATEGY : I Bumped Into A Pretty Decent Retirement Income Opportunit..
07:00a This Bull's Getting Old, So Where Is The Value? - Revisited
Financials ($)
Sales 2017 75 842 M
EBIT 2017 22 815 M
Net income 2017 16 213 M
Debt 2017 17 708 M
Yield 2017 2,49%
P/E ratio 2017 22,42
P/E ratio 2018 18,24
EV / Sales 2017 5,00x
EV / Sales 2018 4,53x
Capitalization 361 535 M
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Average target price 136 $
Spread / Average Target 1,2%
EPS Revisions
Managers
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Dominic J. Caruso Chief Financial Officer & Vice President
Paulus Stoffels Chief Scientific Officer & Executive VP
Charles O. Prince Independent Director
William David Perez Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON15.83%361 535
NOVARTIS7.89%219 476
ROCHE HOLDING LTD.3.78%218 387
PFIZER2.06%197 412
MERCK AND COMPANY6.03%170 241
SANOFI6.97%122 091